Test Price
2,800 AED✅ Home Collection Available
SPG7 Gene Sequencing (NGS) – Hereditary Spastic Paraplegia Type 7
Executive Summary & Core Metrics
Executive Summary
Our SPG7 Genetic Test delivers 99.9% diagnostic sensitivity for Hereditary Spastic Paraplegia type 7, processed at an ISO 9001:2015‑certified, DHA‑regulated laboratory. Benefit from VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection, telephonic post‑test clinical guidance with a consultant medical geneticist, and instant insurance billing verification through WhatsApp. All handling adheres strictly to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Price: 2,800 AED · Turnaround Time: 3–4 weeks · Sample Type: Whole blood (EDTA) · Methodology: Next‑Generation Sequencing (NGS, coverage >100×)
Test Overview & Methodology
The SPG7 Genetic Test uses next‑generation sequencing to analyze the entire coding region of the SPG7 gene, detecting pathogenic variants linked to Hereditary Spastic Paraplegia type 7 and other progressive spastic‑ataxic disorders. Results support definitive diagnosis, genetic counselling, and personalized neurological surveillance, making it an essential tool for neurogenetics clinics across the UAE.
| Feature | Our SPG7 NGS Test | Closest Alternative (Sanger Panel) |
|---|---|---|
| Methodology | NGS deep sequencing (coverage >100×) | Sanger sequencing of selected exons only |
| Variant Detection | Single‑nucleotide variants, small indels, copy‑number changes | Point mutations and small indels; no CNV analysis |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Diagnostic Sensitivity | 99.9% | ~90–95% (misses deep intronic/regulatory variants) |
| Price | 2,800 AED | 3,500+ AED (often requires additional reflex tests) |
Physician Insight & Safety Protocols
Advisory – Medication Continuity
Do not discontinue any prescribed medication without consulting your treating physician.
Exclusion Criteria (Patient Safety)
- Active systemic infection or febrile illness (risk of sample degradation)
- Inability to provide the minimum blood volume (2 mL whole blood in EDTA)
- Minors without explicit guardian consent (in line with UAE Federal Law No. 2 of 2019)
- Recent blood transfusion (<4 weeks) or allogeneic bone marrow transplant (may interfere with germline DNA analysis)
Emergency Red Flags – Seek Immediate Medical Attention
- Sudden‑onset severe leg weakness or inability to walk
- New seizures, confusion, or loss of consciousness
- Acute visual loss, speech arrest, or facial drop
Patient FAQ & Clinical Guidance
- The SPG7 Genetic Test sequences the entire SPG7 gene to identify hereditary mutations responsible for progressive spastic paraplegia, enabling early therapeutic planning, family risk assessment, and lifestyle adjustments.
- A certified mobile phlebotomist performs a home blood draw using an ISO‑certified cold‑chain kit, with results securely reported online within 3–4 weeks. VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection is available daily from 8 AM to 11 PM.
- Most UAE insurers provide partial or full reimbursement when the test is medically indicated; our team instantly confirms eligibility and submits the claim via WhatsApp at +971 54 548 8731.
1. What is the SPG7 Genetic Test and why should I consider it?
2. How is the sample collected and when will I receive my results?
3. Does insurance cover the SPG7 test and how can I verify?
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Insurance
Our laboratory is licensed under DHA (License No. 1143) and holds ISO 9001:2015 certification. We operate in full alignment with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Direct insurance billing verification and claim initiation are available via WhatsApp at +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | SPG7 Gene Sequencing (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood (EDTA) – VIP Mobile Phlebotomy & Cold‑Chain Home Collection Available |
| Methodology Used | Next‑Generation Sequencing (NGS, coverage >100x) |
| ICD-10-CM Code | G11.4 |
| LOINC Code | 55233-1 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians